Constructive news tone
News Sentiment
B1ME34 sentiment intelligence
BeOne Medicines AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
62/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, +8.0% over four weeks, trend inactive, and materially above fair value.
Guggenheim raises BeOne Medicines stock price target on revenue beat By Investing.com
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Guggenheim raises BeOne Medicines stock price target on revenue beat By Investing.com
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 06 Aug 2026 12:31
- Source
- Investing.com Canada
Earnings call transcript: BeOne Medicines lifts 2026 outlook after strong Q2
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 05 Aug 2026 15:29
- Source
- Investing.com India
BeOne Medicines names R&D chief Wang Lai as co-president to lead global expansion
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 19 Dec 2025 08:00
- Source
- Market source
BeOne Medicines stock hits 52-week high at 304.0 USD By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jul 2025 07:00
- Source
- Investing.com Australia